logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers who have significant controls over the individuals in focus are always inapplicable. The offspring entities and appointments are those entities that the individuals in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Offsprings
Parent entities and officers
Inapplicable
parent relation
Individuals in focus

Grainger, David John, Dr

child relation
Offspring entities and appointments 57
  • 1
    A BIO LIMITED
    13349556
    Active Corporate (5 parents)
    Officer
    2021-04-21 ~ now
    IIF 16 - Director → ME
    Person with significant control
    2021-04-21 ~ now
    IIF 64 - Ownership of shares – More than 25% but not more than 50% → OE
    IIF 64 - Right to appoint or remove directors → OE
    IIF 64 - Ownership of voting rights - More than 25% but not more than 50% → OE
  • 2
    ABC MEDICINES LIMITED
    09778579
    Dissolved Corporate (4 parents)
    Officer
    2015-09-15 ~ dissolved
    IIF 14 - Director → ME
    Person with significant control
    2016-04-06 ~ dissolved
    IIF 71 - Ownership of voting rights - More than 25% but not more than 50% → OE
    IIF 71 - Ownership of shares – More than 25% but not more than 50% → OE
  • 3
    AMPKINE LIMITED
    - now 12065717
    LITHIUM TX LIMITED
    - 2025-02-03 12065717
    HYDROGEN TX LIMITED
    - 2021-04-22 12065717
    Active Corporate (5 parents)
    Officer
    2019-06-24 ~ now
    IIF 31 - Director → ME
    Person with significant control
    2019-06-24 ~ 2025-04-17
    IIF 79 - Right to appoint or remove directors → OE
    IIF 79 - Ownership of shares – 75% or more → OE
    IIF 79 - Ownership of voting rights - 75% or more → OE
  • 4
    APCINTEX LIMITED
    - now 09088717
    SERPIN HAEMOSTATICS LIMITED
    - 2016-04-02 09088717
    Active Corporate (19 parents)
    Officer
    2014-06-16 ~ 2016-12-07
    IIF 41 - Director → ME
  • 5
    BARKWAY HOUSE ESTATES LIMITED
    13307945
    Active Corporate (2 parents, 5 offsprings)
    Officer
    2021-04-01 ~ now
    IIF 23 - Director → ME
    Person with significant control
    2021-04-01 ~ now
    IIF 74 - Ownership of voting rights - More than 25% but not more than 50% → OE
    IIF 74 - Ownership of shares – More than 25% but not more than 50% → OE
  • 6
    BHE ALTAIR LTD
    13311920
    Active Corporate (3 parents)
    Officer
    2021-04-03 ~ now
    IIF 26 - Director → ME
  • 7
    BHE BETELGEUSE LTD
    13312281
    Active Corporate (3 parents)
    Officer
    2021-04-03 ~ now
    IIF 25 - Director → ME
    Person with significant control
    2026-04-14 ~ now
    IIF 67 - Ownership of voting rights - More than 25% but not more than 50% → OE
    IIF 67 - Ownership of shares – More than 25% but not more than 50% → OE
    2022-11-02 ~ 2026-04-14
    IIF 73 - Ownership of voting rights - More than 25% but not more than 50% → OE
    IIF 73 - Ownership of shares – More than 25% but not more than 50% → OE
  • 8
    BHE CAPELLA LTD
    13311663
    Active Corporate (3 parents)
    Officer
    2021-04-03 ~ now
    IIF 24 - Director → ME
  • 9
    BHE DENEB LTD
    13455018
    Active Corporate (3 parents)
    Officer
    2021-06-14 ~ now
    IIF 37 - Director → ME
    Person with significant control
    2022-10-17 ~ now
    IIF 69 - Ownership of shares – More than 25% but not more than 50% → OE
    IIF 69 - Ownership of voting rights - More than 25% but not more than 50% → OE
  • 10
    BHE ELECTRA LTD
    16940160
    Active Corporate (3 parents)
    Officer
    2026-01-02 ~ now
    IIF 33 - Director → ME
  • 11
    BPLETE LIMITED
    - now 13439199
    PROTEOMX LIMITED
    - 2023-11-17 13439199
    Active Corporate (4 parents)
    Officer
    2021-06-04 ~ now
    IIF 17 - Director → ME
    Person with significant control
    2021-06-04 ~ 2023-11-09
    IIF 63 - Ownership of shares – More than 25% but not more than 50% → OE
    IIF 63 - Ownership of voting rights - More than 25% but not more than 50% → OE
    IIF 63 - Right to appoint or remove directors → OE
  • 12
    C21MED I LLP
    OC424406
    Dissolved Corporate (2 parents)
    Officer
    2018-10-09 ~ dissolved
    IIF 46 - LLP Designated Member → ME
    Person with significant control
    2018-10-09 ~ dissolved
    IIF 75 - Ownership of voting rights - More than 25% but not more than 50% → OE
    IIF 75 - Right to appoint or remove members → OE
    IIF 75 - Right to surplus assets - More than 25% but not more than 50% → OE
  • 13
    CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED
    - now 09686738
    MORPHOGEN-IX LIMITED
    - 2023-04-03 09686738
    Dissolved Corporate (15 parents)
    Officer
    2015-07-15 ~ 2021-01-29
    IIF 20 - Director → ME
    2021-11-30 ~ 2023-08-18
    IIF 1 - Director → ME
  • 14
    CENTESSA PHARMACEUTICALS (OREXIA) LIMITED
    - now 11607013
    OREXIA THERAPEUTICS LIMITED
    - 2023-04-03 11607013
    OREXIA LIMITED - 2021-02-24
    Dissolved Corporate (13 parents)
    Officer
    2021-11-30 ~ 2023-08-18
    IIF 6 - Director → ME
  • 15
    CORRECTA4 BIO LIMITED
    10132532
    Dissolved Corporate (4 parents)
    Officer
    2016-04-19 ~ dissolved
    IIF 8 - Director → ME
  • 16
    CRITICAL PRESSURE LIMITED
    10826367
    Liquidation Corporate (7 parents)
    Officer
    2017-10-02 ~ 2021-11-24
    IIF 28 - Director → ME
  • 17
    DC EUROPA LIMITED
    10826961
    Dissolved Corporate (9 parents)
    Officer
    2017-06-20 ~ dissolved
    IIF 9 - Director → ME
  • 18
    ELEMENTS SQUARED LIMITED
    12065441
    Active Corporate (8 parents, 5 offsprings)
    Person with significant control
    2019-06-24 ~ 2019-08-02
    IIF 77 - Right to appoint or remove directors → OE
    IIF 77 - Ownership of shares – More than 25% but not more than 50% → OE
    IIF 77 - Ownership of voting rights - More than 25% but not more than 50% → OE
  • 19
    EPSILON-3 BIO LIMITED
    - now 07289096
    APOE TECHNOLOGIES LIMITED
    - 2012-01-17 07289096
    Dissolved Corporate (14 parents)
    Officer
    2010-06-25 ~ dissolved
    IIF 54 - Director → ME
  • 20
    FINGERPRINT DIAGNOSTICS LTD
    04540637
    Dissolved Corporate (7 parents)
    Officer
    2002-09-20 ~ 2006-06-28
    IIF 57 - Director → ME
  • 21
    FUNXIONAL THERAPEUTICS LIMITED
    05534392
    Dissolved Corporate (19 parents)
    Officer
    2007-12-14 ~ 2013-02-01
    IIF 51 - Director → ME
    2014-09-01 ~ dissolved
    IIF 44 - Director → ME
    2005-08-11 ~ 2006-10-31
    IIF 60 - Director → ME
  • 22
    HUMAN ANTIBODY FACTORY LIMITED
    09812386
    Dissolved Corporate (5 parents)
    Officer
    2015-10-06 ~ dissolved
    IIF 12 - Director → ME
  • 23
    IMHOTEX LIMITED
    12443280
    Active Corporate (5 parents)
    Officer
    2020-02-05 ~ now
    IIF 30 - Director → ME
    Person with significant control
    2020-02-05 ~ 2020-03-02
    IIF 78 - Right to appoint or remove directors → OE
    IIF 78 - Ownership of shares – 75% or more → OE
    IIF 78 - Ownership of voting rights - 75% or more → OE
  • 24
    INEXIA LIMITED
    11607985
    Dissolved Corporate (13 parents)
    Officer
    2021-11-30 ~ 2023-08-18
    IIF 2 - Director → ME
  • 25
    INHIBITAXIN LIMITED
    08582765
    Dissolved Corporate (8 parents)
    Officer
    2013-06-25 ~ dissolved
    IIF 38 - Director → ME
  • 26
    JANPIX LIMITED
    08709519
    Dissolved Corporate (14 parents)
    Officer
    2021-11-30 ~ 2023-08-18
    IIF 7 - Director → ME
  • 27
    JOHNS THERAPEUTICS LIMITED
    - now 06327059 07949383
    PROTEXA THERAPEUTICS LIMITED
    - 2012-03-06 06327059 07949383
    BETA THERAPEUTICS LIMITED
    - 2009-09-21 06327059
    Dissolved Corporate (3 parents)
    Officer
    2007-07-27 ~ dissolved
    IIF 52 - Director → ME
  • 28
    LEVICEPT LTD
    08190142
    Active Corporate (12 parents)
    Officer
    2012-08-23 ~ 2018-06-11
    IIF 50 - Director → ME
  • 29
    LOCKBODY THERAPEUTICS LTD
    - now 10650186
    ULTRAHUMAN SIX LIMITED - 2020-11-15
    Dissolved Corporate (15 parents, 2 offsprings)
    Officer
    2021-11-30 ~ 2023-08-18
    IIF 5 - Director → ME
  • 30
    MEDICXI VENTURES (UK) LLP
    OC402437
    Active Corporate (9 parents)
    Officer
    2016-01-25 ~ 2017-12-31
    IIF 48 - LLP Member → ME
  • 31
    METHUSELAH HEALTH UK LIMITED
    09209003
    Active Corporate (9 parents)
    Officer
    2014-09-09 ~ now
    IIF 42 - Director → ME
  • 32
    ONCOMET LIMITED
    08424564
    Dissolved Corporate (4 parents)
    Officer
    2013-02-28 ~ dissolved
    IIF 43 - Director → ME
  • 33
    PANDEIA THERAPEUTICS LIMITED
    11463856
    Active Corporate (10 parents)
    Officer
    2019-09-19 ~ 2022-12-22
    IIF 22 - Director → ME
  • 34
    PERFECT BALANCE BIO LIMITED
    12885832
    Active Corporate (4 parents)
    Officer
    2020-09-17 ~ now
    IIF 21 - Director → ME
    Person with significant control
    2020-09-17 ~ 2020-10-23
    IIF 66 - Ownership of voting rights - 75% or more → OE
    IIF 66 - Right to appoint or remove directors → OE
    IIF 66 - Ownership of shares – 75% or more → OE
  • 35
    PRONOSTICS LIMITED
    - now 03908499
    SMARTBEAD TECHNOLOGIES LIMITED
    - 2006-12-01 03908499
    SKAR INSTRUMENTS LIMITED - 2000-10-05
    Dissolved Corporate (18 parents)
    Officer
    2006-06-28 ~ 2008-12-16
    IIF 58 - Director → ME
  • 36
    PROTEXA THERAPEUTICS LIMITED
    - now 07949383 06327059
    JOHNS THERAPEUTICS LIMITED
    - 2012-03-06 07949383 06327059
    Dissolved Corporate (2 parents)
    Officer
    2012-02-14 ~ dissolved
    IIF 55 - Director → ME
  • 37
    PURPLE PHARMACEUTICALS LIMITED
    08608036
    Dissolved Corporate (7 parents)
    Officer
    2013-07-12 ~ dissolved
    IIF 32 - Director → ME
  • 38
    REBALANCE (CAMBRIDGE) LIMITED
    10512909
    Dissolved Corporate (5 parents)
    Officer
    2016-12-06 ~ dissolved
    IIF 39 - Director → ME
  • 39
    ROUND EARTH THERAPEUTICS LIMITED
    - now 11966376
    G4X LTD
    - 2019-08-09 11966376
    Dissolved Corporate (7 parents)
    Officer
    2019-08-08 ~ dissolved
    IIF 29 - Director → ME
  • 40
    RXBIOLOGICS LIMITED
    - now 10590235
    RX&D LIMITED
    - 2019-02-07 10590235
    Active Corporate (5 parents)
    Officer
    2017-03-01 ~ now
    IIF 34 - Director → ME
  • 41
    RXCELERATE LIMITED
    - now 08284658
    TCP BIOTECH LIMITED
    - 2013-02-05 08284658
    Active Corporate (8 parents, 6 offsprings)
    Officer
    2012-11-07 ~ now
    IIF 35 - Director → ME
  • 42
    S XPRESS BIO LIMITED
    - now 12216115
    HYDROGEN THERAPEUTICS LIMITED
    - 2025-02-13 12216115
    HELIUM TX LIMITED
    - 2021-04-28 12216115
    Active Corporate (5 parents)
    Officer
    2019-09-25 ~ now
    IIF 19 - Director → ME
    Person with significant control
    2019-09-19 ~ 2020-04-29
    IIF 76 - Ownership of shares – 75% or more → OE
    IIF 76 - Right to appoint or remove directors → OE
    IIF 76 - Ownership of voting rights - 75% or more → OE
  • 43
    SDS THERAPEUTICS LIMITED
    12719780
    Active Corporate (6 parents)
    Officer
    2020-07-05 ~ 2024-01-17
    IIF 18 - Director → ME
    Person with significant control
    2020-07-05 ~ 2020-12-18
    IIF 65 - Ownership of shares – 75% or more → OE
    IIF 65 - Right to appoint or remove directors → OE
    IIF 65 - Ownership of voting rights - 75% or more → OE
  • 44
    STEALTHYX THERAPEUTICS LIMITED
    04491233
    Liquidation Corporate (18 parents)
    Officer
    2014-12-02 ~ 2017-10-31
    IIF 15 - Director → ME
  • 45
    SUPERX LIMITED
    09865177
    Dissolved Corporate (13 parents)
    Officer
    2015-11-10 ~ 2016-01-07
    IIF 13 - Director → ME
  • 46
    TCP ASSET 1 LLP
    - now OC352240
    THE CAMBRIDGE PARTNERSHIP LLP
    - 2013-02-19 OC352240 OC347357... (more)
    TOTAL MEDICAL VENTURES I LLP
    - 2010-02-11 OC352240 OC347357
    Dissolved Corporate (3 parents)
    Officer
    2010-02-11 ~ dissolved
    IIF 49 - LLP Designated Member → ME
  • 47
    TCP INNOVATIONS LIMITED
    04333576
    Dissolved Corporate (8 parents, 5 offsprings)
    Officer
    2001-12-05 ~ dissolved
    IIF 56 - Director → ME
  • 48
    THE CAMBRIDGE PARTNERSHIP LIMITED
    - now 08288375 OC352240... (more)
    TCPI ASSET 1 LIMITED - 2013-04-10
    Active Corporate (5 parents, 68 offsprings)
    Officer
    2014-11-01 ~ now
    IIF 36 - Director → ME
    Person with significant control
    2016-04-06 ~ 2018-04-30
    IIF 70 - Ownership of shares – More than 25% but not more than 50% → OE
  • 49
    THE FOUNDRY (CAMBRIDGE) LIMITED
    - now 10822408
    DC GANYMEDE LIMITED
    - 2018-01-15 10822408
    Active Corporate (2 parents, 1 offspring)
    Officer
    2017-06-16 ~ now
    IIF 10 - Director → ME
    Person with significant control
    2018-01-01 ~ now
    IIF 68 - Right to appoint or remove directors → OE
    IIF 68 - Ownership of shares – 75% or more → OE
    IIF 68 - Ownership of voting rights - 75% or more → OE
  • 50
    TOTAL DIAGNOSTICS LIMITED
    09507375
    Dissolved Corporate (2 parents)
    Officer
    2015-03-24 ~ dissolved
    IIF 27 - Director → ME
    Person with significant control
    2016-04-06 ~ dissolved
    IIF 61 - Ownership of shares – More than 25% but not more than 50% → OE
    IIF 61 - Ownership of voting rights - More than 25% but not more than 50% → OE
  • 51
    TOTAL MEDICAL VENTURES I LLP
    - now OC347357 OC352240
    THE CAMBRIDGE PARTNERSHIP LLP
    - 2010-02-11 OC347357 OC352240... (more)
    Active Corporate (2 parents, 2 offsprings)
    Officer
    2009-07-23 ~ now
    IIF 47 - LLP Designated Member → ME
    Person with significant control
    2016-04-06 ~ now
    IIF 72 - Right to surplus assets - More than 25% but not more than 50% → OE
    IIF 72 - Ownership of voting rights - More than 25% but not more than 50% → OE
    IIF 72 - Has significant influence or control → OE
  • 52
    TOTAL SCIENTIFIC LIMITED
    05952429
    Dissolved Corporate (7 parents)
    Officer
    2012-01-05 ~ dissolved
    IIF 53 - Director → ME
    2006-10-02 ~ 2007-12-18
    IIF 59 - Director → ME
    Person with significant control
    2016-04-06 ~ 2018-04-30
    IIF 62 - Ownership of voting rights - More than 25% but not more than 50% → OE
    IIF 62 - Ownership of shares – More than 25% but not more than 50% → OE
  • 53
    ULTRAHUMAN FOUR LIMITED
    10650089
    Dissolved Corporate (13 parents)
    Officer
    2021-11-30 ~ 2023-08-18
    IIF 4 - Director → ME
  • 54
    ULTRAHUMAN LIMITED
    09885211
    Dissolved Corporate (10 parents)
    Officer
    2015-11-24 ~ 2016-01-19
    IIF 11 - Director → ME
  • 55
    ULTRAHUMAN TWO LIMITED
    10645698
    Dissolved Corporate (13 parents)
    Officer
    2021-11-30 ~ 2023-08-18
    IIF 3 - Director → ME
  • 56
    XO1 LIMITED
    08424622
    Dissolved Corporate (21 parents)
    Officer
    2013-02-28 ~ 2015-03-18
    IIF 40 - Director → ME
  • 57
    Z FACTOR LIMITED
    09274181
    Dissolved Corporate (14 parents)
    Officer
    2014-10-21 ~ 2021-01-29
    IIF 45 - Director → ME

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 14 July 2026 and licensed under the Open Government Licence v3.0.